Other languages Incyte Corporation

Equities

INCY

US45337C1027

Market Closed - Nasdaq Other stock markets 21:00:00 31/05/2024 BST			5-day change	1st Jan Change
57.79 ^USD	+0.86%		+0.84%	-7.96%

05-23	Deutsche Bank Initiates Incyte to Hold Rating With $55 Price Target	MT
05-21	Incyte Acquires 2 Office Buildings in Delaware	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Incyte Completes Acquisition of Escient Pharmaceuticals	05-30
Deutsche Bank Initiates Incyte to Hold Rating With $55 Price Target	05-23
Incyte Acquires 2 Office Buildings in Delaware	05-21
Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings	05-21
Incyte to Present at Upcoming Investor Conference	05-21
Transcript : Incyte Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM	05-15
Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress	05-14
Equities Close Mixed as Markets Weigh Consumer Inflation Survey	05-13
Equities Close Mixed as Markets Parse Consumer Inflation Survey	05-13
Incyte, Squarespace rise; Chimera Investment, Amazon fall, Monday, 5/13/2024	05-13
Equities Mixed Intraday as Markets Analyze Consumer Inflation Survey	05-13
Sector Update: Health Care Stocks Mixed in Afternoon Trading	05-13
Increasing Short-Term Inflation Expectations Weigh on US Equity Indexes Ahead of Consumer, Producer Prices	05-13
US Equity Indexes Trade Mixed as Short-Term Inflation Expectations Increase	05-13
Incyte Corporation announces an Equity Buyback for $1,672 million worth of its shares.	05-13
Sector Update: Health Care Stocks Decline Pre-Bell Monday	05-13
Incyte Launches $1.67 Billion Share Repurchase 'Dutch Auction' Tender Offer; to Buy Back $328 Million of Baker Entities' Shares	05-13
Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock	05-13
Incyte Corporation authorizes a Buyback Plan.	05-12
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates	05-07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Incyte Corporation : Is a big change imminent?

October 26, 2023 at 03:00 pm